NCT00272506

Brief Summary

To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Aug 2002

Typical duration for phase_3 asthma

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2002

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2004

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 6, 2006

Completed
Last Updated

July 12, 2016

Status Verified

January 1, 2006

First QC Date

January 3, 2006

Last Update Submit

July 11, 2016

Conditions

AsthmaLung Diseases

Interventions

inhaled corticosteroidDRUG
long-acting beta2-agonistDRUG

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children through 5 years of age.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

AsthmaLung Diseases

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Vernon Chinchilli

    Milton S. Hershey Medical Center

  • Robert Lemanske

    University of Wisconsin, Madison

  • Fernando Martinez

    University of Arizona

  • Robert Strunk

    Washington University School of Medicine

  • Stanley Szefler

    National Jewish Health

  • Robert Zeiger

    University of California, San Diego

Study Design

Study Type
interventional
Phase
phase 3
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
NIH

Study Record Dates

First Submitted

January 3, 2006

First Posted

January 6, 2006

Study Start

August 1, 2002

Study Completion

September 1, 2004

Last Updated

July 12, 2016

Record last verified: 2006-01